These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20683693)

  • 21. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells.
    Lin HY; Sun M; Lin C; Tang HY; London D; Shih A; Davis FB; Davis PJ
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):182-8. PubMed ID: 19159686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In situ production of sex steroids in human breast carcinoma.
    Suzuki T; Miki Y; Moriya T; Akahira J; Hirakawa H; Ohuchi N; Sasano H
    Med Mol Morphol; 2007 Sep; 40(3):121-7. PubMed ID: 17874044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer.
    Michael P; Roversi G; Brown K; Sharifi N
    Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36580423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal breast cancer, androgens, and aromatase inhibitors.
    Campagnoli C; Pasanisi P; Castellano I; Abbà C; Brucato T; Berrino F
    Breast Cancer Res Treat; 2013 May; 139(1):1-11. PubMed ID: 23572296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.
    Attardi BJ; Page ST; Hild SA; Coss CC; Matsumoto AM
    J Steroid Biochem Mol Biol; 2010 Feb; 118(3):151-61. PubMed ID: 19941958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
    Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
    Moore NL; Buchanan G; Harris JM; Selth LA; Bianco-Miotto T; Hanson AR; Birrell SN; Butler LM; Hickey TE; Tilley WD
    Endocr Relat Cancer; 2012 Aug; 19(4):599-613. PubMed ID: 22719059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.
    Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Wang L; Chan MS; Wing L; Yiu CC; Chow LW; Sasano H
    Horm Cancer; 2011 Feb; 2(1):73-81. PubMed ID: 21761341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors.
    Mistry P; Griffiths K; Maynard PV
    J Steroid Biochem; 1986 Jun; 24(6):1117-25. PubMed ID: 3736038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
    Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
    Sikora MJ; Cordero KE; Larios JM; Johnson MD; Lippman ME; Rae JM
    Breast Cancer Res Treat; 2009 May; 115(2):289-96. PubMed ID: 18521740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma.
    Tanaka S; Miki Y; Hashimoto C; Takagi K; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
    Mol Cell Endocrinol; 2015 Feb; 401():56-64. PubMed ID: 25475427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
    Cops EJ; Bianco-Miotto T; Moore NL; Clarke CL; Birrell SN; Butler LM; Tilley WD
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):236-43. PubMed ID: 18515094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells.
    Granata OM; Cocciadifero L; Campisi I; Miceli V; Montalto G; Polito LM; Agostara B; Carruba G
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):290-5. PubMed ID: 19429435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.
    Mohler JL; Titus MA; Bai S; Kennerley BJ; Lih FB; Tomer KB; Wilson EM
    Cancer Res; 2011 Feb; 71(4):1486-96. PubMed ID: 21303972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
    Macedo LF; Guo Z; Tilghman SL; Sabnis GJ; Qiu Y; Brodie A
    Cancer Res; 2006 Aug; 66(15):7775-82. PubMed ID: 16885381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.